Seoulin Bioscience Co.Ltd (038070) — Long-term Investment Intensity
Seoulin Bioscience Co.Ltd (038070) has a Long-term Investment Intensity of 7.5% as of December 2019. Long-term investments of ₩6.08 Billion represent 7.5% of total assets of ₩80.71 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check cash flow reinvestment rate of Seoulin Bioscience Co.Ltd to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Seoulin Bioscience Co.Ltd Long-term Investment Intensity (2014–2019)
This chart shows how Seoulin Bioscience Co.Ltd's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of December 2019, the intensity stands at 7.5%, reflecting long-term investments of ₩6.08 Billion against total assets of ₩80.71 Billion KRW. Explore 038070 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Seoulin Bioscience Co.Ltd (2014–2019)
The table below presents the year-by-year Long-term Investment Intensity for Seoulin Bioscience Co.Ltd from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 038070 company net worth.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 7.5% | ₩6.08 Billion | ₩80.71 Billion | ▼ -1.8 pp |
| 2018 | 9.3% | ₩6.62 Billion | ₩71.11 Billion | ▲ +0.7 pp |
| 2017 | 8.7% | ₩6.15 Billion | ₩71.04 Billion | ▲ +0.4 pp |
| 2016 | 8.3% | ₩5.51 Billion | ₩66.47 Billion | ▼ -0.1 pp |
| 2015 | 8.4% | ₩5.54 Billion | ₩66.10 Billion | ▲ +0.2 pp |
| 2014 | 8.2% | ₩4.99 Billion | ₩60.72 Billion | — |